Zions Bancorporation, N.A. Biomarin Pharmaceutical Inc Transaction History

Zions Bancorporation, N.A.

$1.24 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	SELL	$86.68 - $100.3 $346 - $401	-4 Reduced 16.0%	21 $1,000
Q4 2022 Feb 10, 2023	SELL	$80.93 - $108.63 $6,959 - $9,342	-86 Reduced 77.48%	25 $2,000
Q3 2022 Nov 08, 2022	BUY	$82.16 - $96.94 $7,065 - $8,336	86 Added 344.0%	111 $9,000
Q2 2022 Aug 05, 2022	SELL	$71.48 - $86.85 $357,757 - $434,684	-5,005 Reduced 99.5%	25 $2,000
Q1 2022 May 13, 2022	SELL	$74.28 - $92.69 $93,147 - $116,233	-1,254 Reduced 19.96%	5,030 $388,000
Q4 2021 Feb 11, 2022	BUY	$71.72 - $91.47 $47,478 - $60,553	662 Added 11.78%	6,284 $555,000
Q3 2021 Nov 10, 2021	BUY	$74.77 - $85.47 $62,507 - $71,452	836 Added 17.47%	5,622 $435,000
Q2 2021 Aug 11, 2021	BUY	$75.51 - $84.79 $41,681 - $46,804	552 Added 13.04%	4,786 $399,000
Q1 2021 May 13, 2021	BUY	$74.73 - $90.69 $51,638 - $62,666	691 Added 19.5%	4,234 $320,000
Q4 2020 Feb 12, 2021	SELL	$72.61 - $90.2 $2,759 - $3,427	-38 Reduced 1.06%	3,543 $311,000
Q3 2020 Nov 13, 2020	SELL	$71.87 - $131.03 $182,262 - $332,292	-2,536 Reduced 41.46%	3,581 $272,000
Q2 2020 Aug 13, 2020	BUY	$79.55 - $124.22 $44,786 - $69,935	563 Added 10.14%	6,117 $754,000
Q1 2020 May 15, 2020	BUY	$71.37 - $96.85 $264,711 - $359,216	3,709 Added 201.03%	5,554 $469,000
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $15,681 - $21,074	-244 Reduced 11.68%	1,845 $156,000
Q3 2019 Nov 13, 2019	BUY	$67.4 - $85.11 $6,066 - $7,659	90 Added 4.5%	2,089 $141,000
Q2 2019 Jul 09, 2019	BUY	$80.35 - $93.9 $61,387 - $71,739	764 Added 61.86%	1,999 $171,000
Q1 2019 May 10, 2019	BUY	$84.2 - $98.62 $3,368 - $3,944	40 Added 3.35%	1,235 $110,000
Q4 2018 Feb 13, 2019	BUY	$80.14 - $106.07 $95,767 - $126,753	1,195 New	1,195 $102,000

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

Black Rock Inc. New York, NY

22.7M
Shares

$1.6 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$1.34 Billion
0.03% of portfolio
Primecap Management CO Pasadena, CA

18.8M
Shares

$1.33 Billion
1.14% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$983 Million
0.72% of portfolio
Capital Research Global Investors Los Angeles, CA

9.69M
Shares

$684 Million
0.18% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Zions Bancorporation, N.A. with notifications on news.

Account